Angiostamp™ 800
Near Infrared Fluorescent and Photoacoustic Imaging Agent

Explore the Possibilities with Angiostamp™800

NIR molecular imaging agent for oncology

Explore The Possibilities of Angiostamp™ 800

AngiostampTM 800 is an organic near-infrared (NIR) fluorescent and photoacoustic imaging agent licensed by Optimal Grenoble, a small animal imaging team in France.

It is a NIR imaging agent targeting the αvβ3 integrin. The αvβ3 integrin is overexpressed at the surface of activated endothelial cells during angiogenesis and in various types of tumor cells.

Initially developed as a contrast agent for tumor detection using fluorescence, AngiostampTM 800 can also be used for detecting tumors with high resolution at depth using photoacoustic imaging.

Fluorescent vs PA contrast agent

Fluorescent Imaging vs Contrast Agents

The left depicts a whole body fluorescent image of a mouse with AngiostampTM 800 (green) in the kidneys.

The right depicts a whole body co-registered high resolution ultrasound and photoacoustic image of a mouse showing photoacoustic signal from AngiostampTM 800 (green) in the kidneys.

Angiostamp™ 800 Resources

Download the PDF
Angiostamp™ 800 Flyer

Download the flyer from Optimal Grenoble to get an overview of what Angiostamp™ 800 can provide for your research studies.

Learn more
Featured Publication
Featured Publication

This publication highlights the use of Angiostamp™ 800 and high resolution photoacoustic imaging to stage liver metastasis in a mouse model.

Learn more
Live Webinar

Presented by Jonathan Lavaud, PhD, Postdoctoral Researcher at Optimal Institute for Advanced Bioscience, Grenoble, France.

Learn more
Request a Quote or Demo